Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data

by Garren Kevin W, Baran Robert W, Dietz Birgitta, Simpson Kit N, Riddler Sharon A, Bhor Menaka, Haubrich Richard H
Published 2011-05-01

Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands

by Kappelhoff Bregt S, Finnern Henrik W, Stegmeijer Simon, Veltman-Starkenburg Christa A, Bos Jasper M, Hubben Gijs AA, Simpson Kit N, Tramarin Andrea, Postma Maarten J
Published 2007-11-01